BioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetsTwo of the largest ever biotech IPOs have gone ahead this week, although both BioNTech and Vir Biotechnology Share XBioNTech and Vir’s mega-IPOs go ahead, but struggle to meet price targetshttps://pharmaphorum.com/news/biontech-and-virs-mega-ipos-go-ahead-but-struggle-to-meet-price-targets/
